MedTrace Logo

Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents

NCT00831883 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2012-12-05

No results posted yet for this study

Summary

The purpose of this study is to develop and pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use.

Conditions

  • Sexually Transmitted Diseases
  • Substance-Related Disorders

Interventions

BEHAVIORAL

Partner-Specific IMB-based HIV risk reduction intervention

5 session partner-specific HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model.

BEHAVIORAL

Healthy Lifestyle

5 session psychoeducational group, designed to provide equivalent time and attention, that focuses on the importance of maintaining a good diet, exercise, and developing health skills.

Sponsors & Collaborators

  • University of Rhode Island

    collaborator OTHER

  • Women and Infants Hospital of Rhode Island

    lead OTHER

Principal Investigators

  • Cynthia Rosengard, PhD, MPH · Women & Infants of Rhode Island

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00831883 on ClinicalTrials.gov